G&S Capital’s Medtronic MDT Stock Holding History

G&S Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-28,913	Closed	-$2.51M	–	159
2026 Q1	$2.51M	Buy	+28,913	New	+$2.77M	0.88%	45
2020 Q2	–	Sell	-540	Closed	-$48K	–	141
2020 Q1	$48K	Buy	540 +2	+0.4%	+$213	0.08%	93
2019 Q4	$61K	Buy	538 +96	+22%	+$10.5K	0.03%	129
2019 Q3	$48K	Buy	442 +2	+0.5%	+$209	0.03%	118
2019 Q2	$43K	Buy	440 +3	+0.7%	+$274	0.03%	131
2019 Q1	$40K	Buy	437 +2	+0.5%	+$179	0.02%	129
2018 Q4	$40K	Buy	435 +78	+22%	+$7.29K	0.04%	108
2018 Q3	$35K	Buy	357 +56	+19%	+$5.18K	0.02%	139
2018 Q2	$26K	Buy	301 +2	+0.7%	+$167	0.02%	140
2018 Q1	$24K	Buy	299 +1	+0.3%	+$82	0.02%	142
2017 Q4	$24K	Buy	+298	New	+$23.9K	0.02%	154

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

G&S Capital's MDT Position: Q2 2026 in Review

G&S Capital sold out of Medtronic (MDT) in Q2 2026, closing a stake of 28,913 shares — an estimated $2.51M sold.

G&S Capital first reported a position in MDT in Q4 2017 and held it in 11 quarters. The position peaked at $2.51M in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

G&S Capital reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
G&S Capital sold 28,913 Medtronic shares in Q2 2026, an estimated $2.51M.
G&S Capital first reported a position in Medtronic in Q4 2017 and held it in 11 quarters.
G&S Capital's Medtronic position peaked at $2.51M in Q1 2026.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on G&S Capital's 13F filing for Q2 2026, filed 10 Jul 2026.